MedTrace Logo

Potency and Precision Investigation

NCT06240091 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 203

Last updated 2025-02-19

Study results available
· View outcomes & findings →

Summary

The overarching goal of this study is to establish initial proof of mechanism for precision interventions in an adult population.

Conditions

  • Depression, Anxiety

Interventions

DEVICE

DISC-MA

DISC-MA is a digital program that utilizes elements from validated psychotherapies (e.g., cognitive behavioral therapy), with a relational agent (Woebot) that engages users in conversations with responses that are selected from a list based on natural language processing.

Sponsors & Collaborators

  • Woebot Health

    lead INDUSTRY

Principal Investigators

  • Tim Campellone, PhD · Woebot Health

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-13
Primary Completion
2024-05-09
Completion
2024-05-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06240091 on ClinicalTrials.gov